Literature DB >> 9810482

The course of schizophrenic psychoses: what do we really know? A selective review from an epidemiological perspective.

A Riecher-Rössler1, W Rössler.   

Abstract

There is only a limited amount of definite knowledge on the course of schizophrenic psychoses, although 100 years have passed since they were first described by Kraepelin as "Dementia praecox". The main reason for this is that most studies done thus far suffer from more or less serious methodological shortcomings: samples were often highly selective; investigations were often not direct, not prospective and almost never continuous, which would be of utmost importance in an episodic disease such as schizophrenia; assessments in older studies were neither standardized nor tested for validity or reliability; in more recent studies they were often not conducted by experienced psychiatrists; patients who refused to participate or who died during the study period were widely neglected. Nevertheless, we have learned that schizophrenic psychoses do not have a steadily deteriorating course ending in "dementia". On the contrary, the course of these psychoses seems very heterogeneous. Due to their methodological shortcomings, studies done thus far even seem to have underestimated heterogeneity by partly neglecting patients with very good outcome, on the one hand, and very poor outcome, on the other hand.

Entities:  

Mesh:

Year:  1998        PMID: 9810482     DOI: 10.1007/s004060050037

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  4 in total

1.  Long-Term Outcomes of First-Admission Psychosis: A Naturalistic 21-Year Follow-Up Study of Symptomatic, Functional and Personal Recovery and Their Baseline Predictors.

Authors:  Victor Peralta; Elena García de Jalón; Lucía Moreno-Izco; David Peralta; Lucía Janda; Ana M Sánchez-Torres; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

2.  [Chronic subdural hemorrhage in a patient with suspected schizophrenia prodrome].

Authors:  U Gschwandtner; S Borgwardt; J Aston; M Drewe; E W Radü; A Riecher-Rössler
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

3.  The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data.

Authors:  Mark Savill; Stavros Orfanos; Richard Bentall; Ulrich Reininghaus; Til Wykes; Stefan Priebe
Journal:  Psychiatry Res       Date:  2016-11-14       Impact factor: 3.222

4.  Prospective Long-Term Cohort Study of Subjects With First-Episode Psychosis Examining Eight Major Outcome Domains and Their Predictors: Study Protocol.

Authors:  Victor Peralta; Lucía Moreno-Izco; Elena García de Jalón; Ana M Sánchez-Torres; Lucía Janda; David Peralta; Lourdes Fañanás; Manuel J Cuesta
Journal:  Front Psychiatry       Date:  2021-03-19       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.